Cortex Announces RESOLVE-AF Trial Evaluating Electrographic Flow® (EGF®) Mapping ...

Retrieved on: 2024-02-01 13:46:48

Tags for this article:

Cardiac arrhythmia

Atrial fibrillation

Epidermal growth factor

Cardiology

Park

Click the tags to see associated articles and topics

Cortex Announces RESOLVE-AF Trial Evaluating Electrographic Flow® (EGF®) Mapping .... View article details on hiswai:

Summary

The article describes the RESOLVE-AF trial by Cortex for their MedTech product, the Ablamap® System, aimed at personalized ablation strategies for cardiac arrhythmias, focusing on atrial fibrillation using EGF mapping in cardiology.

Article found on: menafn.com

View Original Article